OXFORD BIOMEDICA

Oxford Biomedica signs new deal to make AstraZeneca COVID shot

Under the expanded deal, AstraZeneca's will have access to Oxford Biomedica's Oxbox manufacturing facility to produce its shot on an as-needed basis beyond 2022.